Research Directions | April 2024
16 April 2024Covering the latest in MND research developments ...
Covering the latest in MND research developments ...
The dates for the 2024 research symposium have been released...
In the last month we have heard about two Phase III trials testing if the Amylyx drug Relyvrio or TUDCA alone provided benefit for MND patients...
MNDRA has awarded three PhD scholarship top-up grants to outstanding early-career researchers...
Like 81% of Australians, many people living with MND play video games, according to anecdotal evidence. But with MND, gaming can become more complex. Here we share some of the great insights in past work from people living with MND about games and technology.
Covering the latest in MND research developments ...
This process is an opportunity to increase the patient and consumer voice earlier as part of health technology assessment (HTA).
Amylyx Pharmaceuticals Announces Failure of Phase 3 PHOENIX Trial of AMX0035/RELYVRIO in MND.....
MND Australia's submission to the consultation on the federal government's new Aged Care Act ...
In our first State of Play for 2024 we will hear from MND Australia's Dr Ben O'Mara and Dr Taylor Dick from UQ to hear about how technology assist living with MND....